Unchained Labs

Unchained Labs is a privately held provider of specialized life science instrumentation, strategically positioned in the high-growth biologics and cell & gene therapy tools market. The company differentiates itself by developing integrated, problem-solving platforms—such as the Stunner (DLS/UV-Vis), Aunty (DSF), and the Sunny Suite (microfluidic LNP production)—that address key bottlenecks in characterization, formulation, and purification. With a focus on automation and AI-driven workflows via its Stuntman platform, Unchained Labs serves as a critical enabler for accelerating therapeutic development from discovery through GMP production. Its business model is based on capital equipment sales and recurring consumables revenue.

Integrated portfolio of instruments for characterization (DLS, UV/Vis, DSF, interferometry), formulation (microfluidic mixing), and automation (AI-driven workflow), targeting biologics and gene therapy workflows.

Unchained Labs competes with large diversified players like Agilent, Thermo Fisher, and Malvern Panalytical, as well as specialists like Wyatt Technology (DLS) and Formulatrix (protein stability). Its differentiation lies in its focused, problem-solving approach, integrated plate-based formats for high-throughput, and dedicated platforms for emerging modalities like viral vectors and LNPs, areas where broader competitors may have less specialized solutions.